<SEC-DOCUMENT>0001213900-22-022707.txt : 20220429
<SEC-HEADER>0001213900-22-022707.hdr.sgml : 20220429
<ACCEPTANCE-DATETIME>20220429160152
ACCESSION NUMBER:		0001213900-22-022707
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20210429
FILED AS OF DATE:		20220429
DATE AS OF CHANGE:		20220429

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Aptorum Group Ltd
		CENTRAL INDEX KEY:			0001734005
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38764
		FILM NUMBER:		22875055

	BUSINESS ADDRESS:	
		STREET 1:		17 HANOVER SQUARE
		CITY:			LONDON
		STATE:			X0
		ZIP:			W1S 1BN
		BUSINESS PHONE:		852 3953 7700

	MAIL ADDRESS:	
		STREET 1:		17 HANOVER SQUARE
		CITY:			LONDON
		STATE:			X0
		ZIP:			W1S 1BN
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>ea158457-6k_aptorumgroup.htm
<DESCRIPTION>REPORT OF FOREIGN PRIVATE ISSUER
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>UNITED
STATES </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>SECURITIES
AND EXCHANGE COMMISSION </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Washington,
D.C. 20549 </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>FORM
6-K&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;<B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>REPORT
OF FOREIGN PRIVATE ISSUER </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>PURSUANT
TO RULE 13a-16 OR 15d-16&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>UNDER
THE SECURITIES EXCHANGE ACT OF 1934 </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>For
the month of April 2022 </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Commission
File Number: 001-38764</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>APTORUM
GROUP LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">17
Hanover Square</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">London
W1S 1BN, United Kingdom</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>(Address
of principal executive offices)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: &nbsp;&nbsp;Form 20-F &#9746;&#8239;&nbsp;&nbsp;Form
40-F &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On April 29, 2022, Aptorum
Group Limited (the &ldquo;Company&rdquo;) issued a press release. A copy of the press release is attached hereto as Exhibit 99.1.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Neither
this report nor the exhibits attached constitutes an offer to sell, or the solicitation of an offer to buy our securities, nor shall
there be any sale of our securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to
the registration or qualification under the securities laws of any such state or jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
information in this Form 6-K, including the exhibits shall not be deemed to be &ldquo;filed&rdquo; for the purposes of Section 18 of
the Securities Exchange Act of 1934, as amended, and shall not be incorporated by reference into any filing under the Securities Act
of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">This
Form 6-K is hereby incorporated by reference into the registration statements of the Company on Form S-8 (Registration Number 333-232591)
and Form F-3 (Registration Number 333-235819) and into each prospectus outstanding under the foregoing registration statements,&nbsp;to
the extent not superseded by documents or reports subsequently filed or furnished by the Company under the Securities Act of 1933, as
amended, or the Securities Exchange Act of 1934, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>EXHIBIT
INDEX</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; width: 9%; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
    No.</B></FONT></TD>
    <TD STYLE="white-space: nowrap; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; width: 90%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ea158457ex99-1_aptorum.htm">Press Release</A></FONT></TD></TR>

</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>SIGNATURES
</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Aptorum Group Limited</B></FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: April 29, 2022</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Sabrina Khan</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp; </FONT></TD>
    <TD STYLE="width: 31%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sabrina Khan</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>EXHIBIT
INDEX </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; width: 9%; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
    No.</B></FONT></TD>
    <TD STYLE="white-space: nowrap; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; width: 9%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ea158457ex99-1_aptorum.htm">Press Release</A></FONT></TD></TR>

  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">3</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ea158457ex99-1_aptorum.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="ex99-1_001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Aptorum Group Limited Reports 2021 Fiscal Year
End Financial Results and Provides Business Update </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>New York &amp; London &amp; Paris, April 29, 2022 </B>&ndash; Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (&ldquo;Aptorum Group&rdquo; or &ldquo;We&rdquo;), a clinical
stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune diseases and infectious diseases, today
announced financial results for the fiscal year ended December 31, 2021, and provided an update on clinical and corporate developments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="background-color: white">Mr.
Ian Huen, Chief Executive Officer and Executive Director of Aptorum Group, commented &ldquo;Aptorum&rsquo;s operational plans remain
on track. In particular, our lead projects, ALS-4 (targeting infections caused by <I>Staphylococcus aureus</I> including <I>Methicillin-resistant
Staphylococcus aureus</I> (MRSA)) and SACT-1 (targeting neuroblastoma), </FONT>have respectively completed their phase 1 clinical
trials and we are working towards the commencement of the next stage of human clinical trials for further proof of concept of these
2 lead projects in the United States<FONT STYLE="background-color: white">. We are also pleased with the progress of our other lead
project, RPIDD, a liquid biopsy program targeting infectious disease diagnostics which is currently undergoing human clinical
validations in Singapore. We are also excited about previously announced expanded oncology and autoimmune drug discovery programs
targeting unmet mutations and novel biomarkers utilizing first-in-class drug molecules.&nbsp;Last but not least, we are excited about the
near-future commercialization of our woman&rsquo;s health supplement product NativusWell<SUP>&reg;</SUP> in Asia and Europe, which
we hope to be followed by launch in the United States, subject to the successful completion of our registration process. Our team is
currently focused on delivering the above milestones for our stakeholders and we believe 2022 will be an exciting year for the
company.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><B><U>Clinical Pipeline Update and
Upcoming Milestones</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">In 2022, we announced a number of updates for our
lead and other projects:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">-</TD><TD STYLE="text-align: justify">Our ALS-4 (a first in-class anti-virulence based small molecule drug targeting infections caused by Staphylococcus
aureus, including, but not limited to Methicillin Resistant Staphylococcus Aureus (&ldquo;MRSA&rdquo;)) Phase 1 clinical trial is completed.
Dosing and clinical evaluations of the Single Ascending Dose studies (&ldquo;SAD&rdquo;) and Multiple Ascending Dose studies (&ldquo;MAD&rdquo;)
have been completed for a total of 72 healthy subjects, no subjects were dropped from the studies and no serious adverse events observed.
With the encouraging safety data, we are on track to submit an IND application to the United States Food and Drug Administration (&ldquo;US
FDA&rdquo;) this year seeking to initiate a Phase 2 clinical study to assess the safety and efficacy of ALS-4 in patients.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">-</TD><TD STYLE="text-align: justify">Our SACT-1 (a repurposed small molecule drug targeting Neuroblastoma and potentially other cancer types)
Phase 1 clinical trial for assessing relative bioavailability and food effect has been completed with no serious adverse events observed.
Our first patent on SACT-1 has been granted by the US Patent and Trademark Office and the US FDA has also granted an Orphan Drug Designation
for SACT-1 for the treatment of neuroblastoma. We plan to hold an end of Phase 1 meeting and submit a clinical protocol to the US FDA
this year to initiate a Phase 1b/2a clinical study to assess the safety and efficacy of SACT-1 in patients.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">-</TD><TD STYLE="text-align: justify">Our first patent on the molecular based rapid pathogen diagnostics
liquid biopsy technology (&ldquo;RPIDD&rdquo;) has been granted by the US Patent and Trademark Office. We started the clinical validation
of our RPIDD for the diagnosis of pathogens including viruses, bacteria, fungi and parasites. We have been enrolling patients with febrile
neutropenia and sepsis for our clinical validation. Various bacteria and viruses have been detected in these patient samples, including
Escherichia coli, Klebsiella pneumoniae and Herpesviridae. The data have been cross-validated by standard of care diagnostics results
such as blood culture technology. RPIDD achieved high analytical sensitivity and specificity of the clinical samples respectively at both
low depth (60,000 reads) and high depth (1 million reads) sequencing and further clinical validation is ongoing.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">-</TD><TD STYLE="text-align: justify">We launched our oncology and autoimmune discovery and development platform. The platform will initially
focus on non-small cell lung cancer (&ldquo;NSCLC&rdquo;) and autoimmune diseases such as lupus, rheumatoid arthritis, inflammatory bowel
diseases, etc. We are currently conducting optimization for selected candidates as part of its small molecule library for major targets
including, but not limited to EGFR, ALK, KRAS, p53 mutations.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="ex99-1_001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Fiscal Year End Financial Results</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Aptorum Group reported a net loss of $27.1 million
in 2021, as compared to net income of $4.9 million in 2020. The net income in 2020 was mainly driven by the gain on investments in marketable
securities, net of $25.2 million, while there was a loss on investments in marketable securities, net of $8.0 million in 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Research and development expenses were $10.9 million
in 2021 as compared to $11.6 million in 2020. The decrease in research and development expenses in 2021 was primarily due to less sponsored
research to universities in 2021, partly offset by the increase in contracted research organizations services and consultation due to
the development progress of our lead projects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">General and administrative fees were $5.4 million
in 2021 as compared to $4.9 million in 2020. The increase in general and administration fees was mainly due to increase in bonus expenses
to our directors, employees, external consultants and advisors. The increase is partly offset by a significant decrease in travelling
expenses due to the outbreak of COVID-19.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Legal and professional fees were $2.6 million
in 2021 as compared to $2.9 million in 2020. The decrease in legal and professional fees was mainly due to less one-off professional services
engaged during 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Aptorum Group reported $8.3 million of cash and
restricted cash as of December 31, 2021 compared to $3.6 million as of December 31, 2020. The increase in cash and restricted cash was
mainly the result of the proceeds from sales of investment securities of $20.1 million and proceeds from issuance of Class A Ordinary
Shares of $4.0 million in 2021, partly offset by the cash used in operating activities of $14.7 million, net repayment of loan from related
parties of $2.0 million, and loan to a related party of $3.4 million in 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>About Aptorum Group</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Aptorum Group Limited (Nasdaq: APM, Euronext Paris:
APM) is a clinical stage biopharmaceutical company dedicated to the discovery, development and commercialization of therapeutic assets
to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases.
The pipeline of Aptorum is also enriched through (i) the establishment of drug discovery platforms that enable the discovery of new therapeutics
assets through, e.g. systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of
metabolic diseases; and (ii) the co-development of a novel molecular-based rapid pathogen identification and detection diagnostics technology
with Accelerate Technologies Pte Ltd, commercialization arm of the Singapore&rsquo;s Agency for Science, Technology and Research.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For more information about the Company, please
visit www.aptorumgroup.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Investor Relations</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">investor.relations@aptorumgroup.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">+44 20 80929299</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Redchip &ndash; Financial Communications United States</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Investor relations</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dave Gentry</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">dave@redchip.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">+1 407 491 4498</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Actifin &ndash; Financial Communications Europe</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Investor relations</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ghislaine Gasparetto</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ggasparetto@actifin.fr</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">+33 1 56 88 11 22</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="ex99-1_001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Disclaimer and Forward-Looking Statements</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This press release does not constitute an offer to sell or a solicitation
of offers to buy any securities of Aptorum Group.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This press release includes statements concerning Aptorum Group Limited
and its future expectations, plans and prospects that constitute &ldquo;forward-looking statements&rdquo; within the meaning of the US
Private Securities Litigation Reform Act of 1995. For this purpose, any statements contained herein that are not statements of historical
fact may be deemed to be forward-looking statements. In some cases, you can identify forward-looking statements by terms such as &ldquo;may,&rdquo;
&ldquo;should,&rdquo; &ldquo;expects,&rdquo; &ldquo;plans,&rdquo; &ldquo;anticipates,&rdquo; &ldquo;could,&rdquo; &ldquo;intends,&rdquo;
&ldquo;target,&rdquo; &ldquo;projects,&rdquo; &ldquo;contemplates,&rdquo; &ldquo;believes,&rdquo; &ldquo;estimates,&rdquo; &ldquo;predicts,&rdquo;
&ldquo;potential,&rdquo; or &ldquo;continue,&rdquo; or the negative of these terms or other similar expressions. Aptorum Group has based
these forward-looking statements, which include statements regarding projected timelines for application submissions and trials, largely
on its current expectations and projections about future events and trends that it believes may affect its business, financial condition
and results of operations. These forward-looking statements speak only as of the date of this press release and are subject to a number
of risks, uncertainties and assumptions including, without limitation, risks related to its announced management and organizational changes,
the continued service and availability of key personnel, its ability to expand its product assortments by offering additional products
for additional consumer segments, development results, the company&rsquo;s anticipated growth strategies, anticipated trends and challenges
in its business, and its expectations regarding, and the stability of, its supply chain, and the risks more fully described in Aptorum
Group&rsquo;s Form 20-F and other filings that Aptorum Group may make with the SEC in the future, as well as the prospectus that received
the French Autorit&eacute; des March&eacute;s Financiers visa n&deg;20-352 on 16 July 2020. As a result, the projections included in such
forward-looking statements are subject to change and actual results may differ materially from those described herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Aptorum Group assumes no obligation to update any forward-looking statements
contained in this press release as a result of new information, future events or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This announcement is not a prospectus within the meaning of the Regulation
(EU) n&deg;2017/1129 of 14 June 2017 as amended by Regulations Delegated (EU) n&deg;2019/980 of 14 March 2019 and n&deg;2019/979 of 14
March 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This press release is provided &ldquo;as is&rdquo; without any representation
or warranty of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B><IMG SRC="ex99-1_001.jpg" ALT="">&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>APTORUM GROUP LIMITED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE
INCOME (LOSS)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>For Years Ended December 31, 2021 and 2020</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Stated in U.S. Dollars)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year Ended<BR> December&nbsp;31,<BR> 2021</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year Ended<BR> December&nbsp;31,<BR> 2020</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold">Revenue</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left; text-indent: -9pt; padding-left: 9pt">Healthcare services income</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">1,541,778</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">911,509</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -9pt; padding-left: 9pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; text-indent: -9pt; padding-left: 9pt">Operating expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt">Cost of healthcare services</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,459,924</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,015,023</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt">Research and development expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(10,869,642</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(11,586,923</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt">General and administrative fees</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(5,409,302</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,853,488</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt">Legal and professional fees</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,617,834</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,854,225</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Other operating expenses</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(392,511</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(877,391</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Total operating expenses</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(20,749,213</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(21,187,050</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -9pt; padding-left: 9pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; text-indent: -9pt; padding-left: 9pt">Other (loss) income, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt">(Loss) gain on investments in marketable securities, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(8,031,595</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,241,556</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt">Loss on investments in derivatives, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,289</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(199,031</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt">Gain on use of digital currencies</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,918</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt">Gain on derecognition of non-financial assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">75,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt">Interest expense, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(93,601</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(243,628</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt">Rental income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">30,894</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt">Loss on disposal of subsidiaries</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,638</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Sundry income</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">146,347</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">365,917</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Total other (loss) income, net</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(7,906,858</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">25,195,708</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -9pt; padding-left: 9pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Net (loss) income</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(27,114,293</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">4,920,167</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt">Net loss attributable to non-controlling interests</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,065,904</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,146,687</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Deemed dividend related to warrants down round provision</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(755,514</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -9pt; padding-left: 9pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Net (loss) income attributable to Aptorum Group Limited</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(25,048,389</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">6,311,340</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -9pt; padding-left: 9pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt">Net (loss) income per share attributable to Aptorum Group Limited</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -9pt; padding-left: 9pt">-&nbsp;&nbsp;Basic</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(0.71</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.20</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">-&nbsp;&nbsp;Diluted</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(0.71</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">0.20</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -9pt; padding-left: 9pt">Weighted-average shares outstanding</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -9pt; padding-left: 9pt">-&nbsp;&nbsp;Basic</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">35,033,970</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">31,135,882</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">-&nbsp;&nbsp;Diluted</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">35,033,970</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">31,534,473</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -9pt; padding-left: 9pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; text-indent: -9pt; padding-left: 9pt">Net (loss) income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(27,114,293</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">4,920,167</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -9pt; padding-left: 9pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; text-indent: -9pt; padding-left: 9pt">Other comprehensive (loss) income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Exchange differences on translation of foreign operations</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(55,315</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">58,848</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Other comprehensive (loss) income</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(55,315</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">58,848</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -9pt; padding-left: 9pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; text-indent: -9pt; padding-left: 9pt">Comprehensive (loss) income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(27,169,608</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,979,015</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt">Comprehensive loss attributable to non-controlling interests</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,065,904</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,146,687</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Deemed dividend related to warrants down round provision</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(755,514</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -9pt; padding-left: 9pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Comprehensive (loss) income attributable to the shareholders of Aptorum Group Limited</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(25,103,704</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">6,370,188</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="ex99-1_001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>APTORUM GROUP LIMITED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONSOLIDATED BALANCE SHEETS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>December 31, 2021 and 2020</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Stated in U.S. Dollars)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&nbsp;31,<BR> 2021</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&nbsp;31,<BR> 2020</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold">ASSETS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Current assets:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%">Cash</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">8,131,217</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">3,495,231</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Restricted cash</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">130,270</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">130,125</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Digital currencies</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,539</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Accounts receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">78,722</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">62,221</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Inventories</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">35,775</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">39,133</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Marketable securities, at fair value</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">236,615</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">28,384,944</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Investments in derivatives</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,289</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Amounts due from related parties</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">47,754</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Due from brokers</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">76,380</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">160,337</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Loan receivable from a related party</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,358,089</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Other receivables and prepayments</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">593,478</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,378,996</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total current assets</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">12,688,300</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">33,656,815</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Property, plant and equipment, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,731,116</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,686,323</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Operating lease right-of-use assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">154,439</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">547,389</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Long-term investments</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,156,907</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,079,707</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Intangible assets, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">880,256</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">964,857</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Long-term deposits</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">296,225</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">296,225</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 4pt">Total Assets</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">21,907,243</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">44,231,316</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">LIABILITIES AND EQUITY</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold">LIABILITIES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Current liabilities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Amounts due to related parties</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">11,389</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">145,926</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Accounts payable and accrued expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,172,565</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,240,772</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Finance lease liabilities current</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">47,923</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">49,396</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Operating lease liabilities, current</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">145,391</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">432,600</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total current liabilities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">4,377,268</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">3,868,694</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Finance lease liabilities, non-current</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">47,923</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Operating lease liabilities, non-current</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23,853</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">155,121</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Loan payables to related parties</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,007,285</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 4pt">Total Liabilities</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">4,401,121</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">6,079,023</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Commitments and contingencies</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">-</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">-</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold">EQUITY</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 10pt">Class A Ordinary Shares ($1.00 par value; 60,000,000 shares authorized, 13,202,408 and 11,584,324 shares issued and outstanding as of December&nbsp;31, 2021 and 2020, respectively)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">13,202,408</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">11,584,324</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt">Class B Ordinary Shares ($1.00 par value; 40,000,000 shares authorized, 22,437,754 shares issued and outstanding as of December&nbsp;31, 2021 and 2020)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22,437,754</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22,437,754</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Additional paid-in capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">43,506,717</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">38,247,903</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Accumulated other comprehensive (loss) income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,019</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">53,296</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Accumulated deficit</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(55,537,515</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(30,489,126</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Total equity attributable to the shareholders of Aptorum Group Limited</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23,607,345</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">41,834,151</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Non-controlling interests</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(6,101,223</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(3,681,858</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total equity</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">17,506,122</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">38,152,293</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 4pt">Total Liabilities and Equity</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">21,907,243</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">44,231,316</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex99-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  M .\# 2(  A$! Q$!_\0
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MR7-%IK75;:;_ '"G"=.7).+C)6]UJSUVTUWZ&A17X9?LN?\ !PY_P3M_:_\
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MC\4Z[K]]8ZAJCQZ9HBW=D\UGINF:9>7VJWSW$=O91+!&[-<WEG!/\Y?L$?\
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M"WAI])\,P7\IO+FYO6T3PMI<MC:6L,ES=ZYXM\3WR(OFZIK3LO\ =G_P6_\
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M_P#!H!_R?S^T#_V:?KW_ *MCX55^37["G["EW^T3^S'_ ,%%OVS?B+8:C?\
MP]_9;^ /B&Y\,ZC=338\2?M ^,[FQ30O,NY)3)J"^#_#TVL^*=;0F21-4U'P
M@UT6AU!P_P"LO_!H!_R?S^T#_P!FGZ]_ZMCX55G!RE7ISEO.?,O3WH_<K67H
MWU-JRA#!5Z,-?8TXPD_[SY)OYN]WV;2Z']4'_!6SXV_\%&OA)XC^"-O^PI^P
MG\+_ -L72-;T3QS/\1]3^(?A.3Q+/X$U&RO_  S'X;L-*DC\<^#_ +'%KMM<
M:O<7:&._^T/ID!#V_DE9?R /[9G_  <(D$?\.1/V:.?7X67##\O^%V<_2OV=
M_P""J7[,/_!2#]H3Q#\&;W]@_P#;B\.?LB:3X7T;QI:_$?3->U76--;QQJ.J
M7OAV7PW?6RZ5X8\0K.NAVUEJ]O(9VM3$=201K,)',?Y.?\.U_P#@X>_Z33_#
MS_PI_%O_ ,[2NF:GS.RK6Z.'LN79;<RO]_7R//HRHJE%2>$YM;^T^L\_Q/XO
M9ODVVMTM?6Y]1?M^_M+?\%A/ 'QUTS0OV7/^"77P1_:)^&DOPH^&>JWGC[Q?
MX$EUO5K7QOJ6@"Y\8>$4OD^)WAU5T_PMJK/IMC:?V>YMXEP;RZ#AZ^)/^&S?
M^#A'_I"'^S3_ .&MN/\ Y]E=S_P[7_X.'O\ I-/\//\ PI_%O_SM*/\ AVO_
M ,'#W_2:?X>?^%/XM_\ G:4G[1MOEQ"OT3HV7WW_ #+BZ$8J+E@I65KOZW=^
M;LTK^B2/CG_@XG_:1'Q=_;3T_P"#6C:@MSX8_9S\(67AF>&&1GMCX^\8):>)
M_%UQG_5M-;Z?+X6T*Y4$FWN]#NH6VR"45_5W_P $M/V>A^S+^PA^SW\.+O3_
M .SO$M]X-MOB!XVA=6%TOB[XB.WBW5+6^+JKM=:+#J=GX=;</W<.CPPK\D2
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M]_8?_9?E_9E\6?'NX^/_ (8\ >+-1O/AIK>H> 3X#U+PAX6\2J-7O/!;0_\
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2_P"2*^NXK_G\_P#P&'_R!__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
